Alta Bates Summit Medical Center - Summit Campus — Oakland, California

Alta Bates Summit Medical Center - Summit Campus is a clinical research site located in Oakland, California, United States 94609.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Alta Bates Summit Medical Center - Summit Campus has participated in 162 clinical trials with 58 currently active.

Therapeutic areas: Breast Cancer, Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7.

Sponsors: NSABP Foundation Inc, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alta Bates Summit Medical Center - Summit Campus?

Alta Bates Summit Medical Center - Summit Campus has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alta Bates Summit Medical Center - Summit Campus conducted?

Alta Bates Summit Medical Center - Summit Campus has 162 clinical trials on record, with 58 currently active. Their work covers Breast Cancer, Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7.

Is Alta Bates Summit Medical Center - Summit Campus accredited by Crixeo Health?

Alta Bates Summit Medical Center - Summit Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alta Bates Summit Medical Center - Summit Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.